Syneos Health Stockholders Approve Agreement with Private Investment Consortium
MORRISVILLE, N.C., Aug. 02, 2023 (GLOBE NEWSWIRE) — Syneos Health, Inc. (Nasdaq: SYNH) (“Syneos Health”…
Year: 2023
Yield10 Bioscience Announces Positive Results in the First Field Test of Stacked Herbicide Tolerance Traits in Camelina, Supporting Large Acreage Production of Low-carbon Intensity Feedstock Oil for the Biofuel Market
–Findings demonstrate a key advancement in the development of proprietary Camelina varieties tolerant to application…
Yield10 Bioscience Announces Positive Results in the First Field Test of Stacked Herbicide Tolerance Traits in Camelina, Supporting Large Acreage Production of Low-carbon Intensity Feedstock Oil for the Biofuel Market
–Findings demonstrate a key advancement in the development of proprietary Camelina varieties tolerant to application…
Adamis Pharmaceuticals Announces Pricing of $8.0 Million Public Offering
SAN DIEGO, Aug. 02, 2023 (GLOBE NEWSWIRE) — Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage biopharmaceutical…
Adamis Pharmaceuticals Announces Pricing of $8.0 Million Public Offering
SAN DIEGO, Aug. 02, 2023 (GLOBE NEWSWIRE) — Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage biopharmaceutical…
RVL Pharmaceuticals plc to Discuss Second Quarter 2023 Financial Results and Provide Commercial Update
— Conference call to be held Monday, August 14, 2023, at 8:30 a.m. ET —…
RVL Pharmaceuticals plc to Discuss Second Quarter 2023 Financial Results and Provide Commercial Update
— Conference call to be held Monday, August 14, 2023, at 8:30 a.m. ET —…
Aridis Pharmaceuticals Announces $2 Million Offering
Los Gatos, Calif., Aug. 02, 2023 (GLOBE NEWSWIRE) — Aridis Pharmaceuticals, Inc. (OTC: ARDS), a…
Aridis Pharmaceuticals Announces $2 Million Offering
Los Gatos, Calif., Aug. 02, 2023 (GLOBE NEWSWIRE) — Aridis Pharmaceuticals, Inc. (OTC: ARDS), a…
X4 Pharmaceuticals to Report Second-Quarter 2023 Financial Results and Host a Conference Call and Webcast on August 10, 2023
BOSTON, Aug. 02, 2023 (GLOBE NEWSWIRE) — X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a leader in the…
X4 Pharmaceuticals to Report Second-Quarter 2023 Financial Results and Host a Conference Call and Webcast on August 10, 2023
BOSTON, Aug. 02, 2023 (GLOBE NEWSWIRE) — X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a leader in the…
Candel Therapeutics to Participate in the Canaccord Genuity 43rd Annual Growth Conference
NEEDHAM, Mass., Aug. 02, 2023 (GLOBE NEWSWIRE) — Candel Therapeutics, Inc. (Candel or the Company)…
Candel Therapeutics to Participate in the Canaccord Genuity 43rd Annual Growth Conference
NEEDHAM, Mass., Aug. 02, 2023 (GLOBE NEWSWIRE) — Candel Therapeutics, Inc. (Candel or the Company)…
First Patient Enrolled in LEOPARD, an Investigator-Initiated Trial, with OCS-01 Eye Drops for the Treatment of Cystoid Macular Edema
LEOPARD trial initiation follows recent positive data from OCS-01 eye drops from the Stage 1…
First Patient Enrolled in LEOPARD, an Investigator-Initiated Trial, with OCS-01 Eye Drops for the Treatment of Cystoid Macular Edema
LEOPARD trial initiation follows recent positive data from OCS-01 eye drops from the Stage 1…
PDS Biotech to Present at BTIG Virtual Biotechnology Conference 2023
PRINCETON, N.J., Aug. 02, 2023 (GLOBE NEWSWIRE) — PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage…
PDS Biotech to Present at BTIG Virtual Biotechnology Conference 2023
PRINCETON, N.J., Aug. 02, 2023 (GLOBE NEWSWIRE) — PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage…
Centers For Medicare & Medicaid Services Creates New Hospital Inpatient Payment for Coronary Intravascular Lithotripsy
Three New IVL-Specific Diagnostic Related Groups (DRGs) with Increased Payments Go Into Effect October 1,…
Centers For Medicare & Medicaid Services Creates New Hospital Inpatient Payment for Coronary Intravascular Lithotripsy
Three New IVL-Specific Diagnostic Related Groups (DRGs) with Increased Payments Go Into Effect October 1,…
Aquestive Therapeutics to Participate in 2023 Wedbush PacGrow Healthcare Conference
WARREN, N.J., Aug. 02, 2023 (GLOBE NEWSWIRE) — Aquestive Therapeutics, Inc. (NASDAQ: AQST) (the “Company”…